Literature DB >> 8225882

The demonstration of human tumors on nude mice using gadolinium-labelled monoclonal antibodies for magnetic resonance imaging.

S Göhr-Rosenthal1, H Schmitt-Willich, W Ebert, J Conrad.   

Abstract

RATIONAL AND
OBJECTIVES: The authors describe the magnetic resonance imaging (MRI) of a tumor in a nude mouse tumor model by means of an antibody-polylysine (Gd-DTPA) conjugate.
METHODS: The monoclonal antibody, (MAB) RA96, was coupled to a polymeric gadolinium complex after periodate oxidation. This polymer, which consists of a polylysine backbone and complexing DTPA subunits, complexes an average of 65 gadolinium ions.
RESULTS: The immunoreactivity of the conjugates was reduced by an average of only 30% compared with the unbound MAB RA96. Biodistribution studies in nude mice with subcutaneously implanted human colon carcinomas (WiDr [specific] and HT29 [control]) revealed a tissue concentration in the specific tumor of 8.72% of the dose applied per gram despite the high molecular weight of the conjugates.
CONCLUSIONS: This tissue concentration is sufficient to achieve tumor-specific signal enhancement in the WiDr tumor on MRI. The problem of the high doses of protein required for MRI and possible solutions are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225882

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  13 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 2.  Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.

Authors:  Aaron Joseph L Villaraza; Ambika Bumb; Martin W Brechbiel
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Evaluation of CLT1-(Gd-DTPA) for Cancer MR Molecular Imaging in a Mouse Breast Cancer Model.

Authors:  Furong Ye; Eun-Kee Jeong; Denis Parker; Zheng-Rong Lu
Journal:  Bo Pu Xue Za Zhi       Date:  2011

Review 4.  Recent trends in antibody-based oncologic imaging.

Authors:  Sukhwinder Kaur; Ganesh Venktaraman; Maneesh Jain; Shantibhusan Senapati; Pradeep K Garg; Surinder K Batra
Journal:  Cancer Lett       Date:  2011-10-20       Impact factor: 8.679

5.  Noninvasive visualization of in vivo drug delivery of poly(L-glutamic acid) using contrast-enhanced MRI.

Authors:  Furong Ye; Tianyi Ke; Eun-Kee Jeong; Xuli Wang; Yongen Sun; Melody Johnson; Zheng-Rong Lu
Journal:  Mol Pharm       Date:  2006 Sep-Oct       Impact factor: 4.939

6.  Molecular Imaging of Cancer: Applications of Magnetic Resonance Methods.

Authors:  Barjor Gimi; Arvind P Pathak; Ellen Ackerstaff; Kristine Glunde; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2005-04-01       Impact factor: 10.961

7.  Folate receptor-mediated targeted polymeric gadolinium complexes for magnetic resonance imaging in pulmonary tumor xenografts.

Authors:  Zheng Yuan; Wen-Tao Li; Xiao-Dan Ye; Shi-Yuan Liu; Xiang-Sheng Xiao
Journal:  Exp Ther Med       Date:  2012-03-05       Impact factor: 2.447

8.  Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI.

Authors:  Amber L Doiron; Kevin Chu; Adeel Ali; Lisa Brannon-Peppas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

9.  Molecular MR imaging for visualizing ICAM-1 expression in the inflamed synovium of collagen-induced arthritic mice.

Authors:  Sang-Il Lee; Sang Yong Lee; Kwon-Ha Yoon; Kyu-Sil Choi; Kyu Yun Jang; Wan-Hee Yoo; Sang-Hyon Kim; Tae Hyun Choi; Jin Gyoon Park
Journal:  Korean J Radiol       Date:  2009-08-25       Impact factor: 3.500

10.  Preparation and in vitro studies of MRI-specific superparamagnetic iron oxide antiGPC3 probe for hepatocellular carcinoma.

Authors:  Youwei Li; Zhengguang Chen; Fei Li; Jichen Wang; Zongming Zhang
Journal:  Int J Nanomedicine       Date:  2012-08-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.